Literature DB >> 21473963

No association between hemoglobin A1c and in-hospital mortality in patients with diabetes and acute myocardial infarction.

Kathryn A Britton1, Vikas Aggarwal, Anita Y Chen, Karen P Alexander, Ezra Amsterdam, Elizabeth Fraulo, Paul Muntner, Laine Thomas, Darren K McGuire, Stephen D Wiviott, Matthew T Roe, Ulrich K Schubart, Caroline S Fox.   

Abstract

BACKGROUND: Patients with diabetes have increased in-hospital mortality following acute myocardial infarction (AMI), with studies suggesting higher risk with both hypoglycemia and hyperglycemia. We assessed whether a J-shaped relation exists between hemoglobin A1c (A1C) in patients with diabetes and AMI.
METHODS: We assessed the associations between A1C and in-hospital mortality using data from a nationwide sample of AMI patients who had both prior diabetes and measurement of A1C (N = 15,337).
RESULTS: When evaluated continuously, we observed no evidence of a J-shaped relation between A1C and in-hospital mortality in multivariable analysis (test for linearity P = .89). Patients with lowest (<5.5%) and highest A1C (≥9.5%) had a crude mortality rate of 4.6% and 2.8%, respectively, compared with 3.8% among those in the referent A1C category (6.5% to <7%). In multivariable regression, we observed no association between low A1C (<5.5%, odds ratio 0.81, 95% CI 0.47-1.39) or high A1C (A1C ≥9.5, odds ratio 1.31, 95% CI 0.94-1.83) and mortality as compared with the referent group. These findings can only be generalized to the subset of patients with diabetes who had A1C assessed during their hospitalization; these patients tended to be healthier than those in whom A1C was not assessed.
CONCLUSION: In this large contemporary cohort of patients with diabetes presenting with AMI, we did not observe a J-shaped association between A1C and mortality.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21473963      PMCID: PMC3199292          DOI: 10.1016/j.ahj.2010.12.004

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  24 in total

1.  U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction.

Authors:  Duane S Pinto; Adam H Skolnick; Ajay J Kirtane; Sabina A Murphy; Hal V Barron; Robert P Giugliano; Christopher P Cannon; Eugene Braunwald; C Michael Gibson
Journal:  J Am Coll Cardiol       Date:  2005-07-05       Impact factor: 24.094

2.  Relation of chronic and acute glycemic control on mortality in acute myocardial infarction with diabetes mellitus.

Authors:  Jie J Cao; Michael Hudson; Michelle Jankowski; Fred Whitehouse; W Douglas Weaver
Journal:  Am J Cardiol       Date:  2005-07-15       Impact factor: 2.778

3.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

4.  Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes.

Authors:  J R Timmer; J P Ottervanger; H J G Bilo; J H E Dambrink; K Miedema; J C A Hoorntje; F Zijlstra
Journal:  QJM       Date:  2006-02-27

5.  Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events.

Authors:  Ann-Marie Svensson; Darren K McGuire; Putte Abrahamsson; Mikael Dellborg
Journal:  Eur Heart J       Date:  2005-04-08       Impact factor: 29.983

6.  Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.

Authors:  Elizabeth Selvin; Spyridon Marinopoulos; Gail Berkenblit; Tejal Rami; Frederick L Brancati; Neil R Powe; Sherita Hill Golden
Journal:  Ann Intern Med       Date:  2004-09-21       Impact factor: 25.391

7.  Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.

Authors:  Kay-Tee Khaw; Nicholas Wareham; Sheila Bingham; Robert Luben; Ailsa Welch; Nicholas Day
Journal:  Ann Intern Med       Date:  2004-09-21       Impact factor: 25.391

8.  Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events.

Authors:  Kristen Franklin; Robert J Goldberg; Frederick Spencer; Werner Klein; Andrzej Budaj; David Brieger; Michel Marre; Philippe Gabriel Steg; Neelam Gowda; Joel M Gore
Journal:  Arch Intern Med       Date:  2004-07-12

9.  Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk.

Authors:  Mikhail Kosiborod; Silvio E Inzucchi; Harlan M Krumholz; Lan Xiao; Philip G Jones; Suzanne Fiske; Frederick A Masoudi; Steven P Marso; John A Spertus
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

10.  Prognostic value of admission plasma glucose and HbA in acute myocardial infarction.

Authors:  S Hadjadj; D Coisne; G Mauco; S Ragot; F Duengler; P Sosner; F Torremocha; D Herpin; R Marechaud
Journal:  Diabet Med       Date:  2004-04       Impact factor: 4.359

View more
  10 in total

1.  Rural-urban differences in acute myocardial infarction mortality: Evidence from Nebraska.

Authors:  Soumitra Sudip Bhuyan; Yang Wang; Samuel Opoku; Ge Lin
Journal:  J Cardiovasc Dis Res       Date:  2014-02-22

2.  Efficacy and safety of different doses of tirofiban combined with ticagrelor on diabetic patients with AMI receiving in emergency percutaneous coronary intervention (PCI).

Authors:  Yang Liu; Hengliang Liu; Zhenxuan Hao; Guoying Geng; Qi Chen; Wenjie Han; Kailong Jia; Yuxin Zhou
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Effects of Coronary Arterial Injection of Tirofiban on Diabetes Mellitus Complicated with Acute Myocardial Infarction in the Elderly.

Authors:  Yang Liu; Heng-Liang Liu; Guo-Ying Geng; Ning Ba; Song-Bin Jing; Wei Guo; Zhi-Fang Zhang
Journal:  Acta Cardiol Sin       Date:  2013-11       Impact factor: 2.672

4.  The impact of metabolic control and QTc prolongation on all-cause mortality in patients with type 2 diabetes and foot ulcers.

Authors:  K Fagher; M Löndahl
Journal:  Diabetologia       Date:  2013-02-12       Impact factor: 10.122

5.  Comparison of primary coronary percutaneous coronary intervention between Diabetic Men and Women with acute myocardial infarction.

Authors:  Heng-Liang Liu; Yang Liu; Zhen-Xuan Hao; Guo-Ying Geng; Zhi-Fang Zhang; Song-Bin Jing; Ning Ba; Wei Guo
Journal:  Pak J Med Sci       Date:  2015 Mar-Apr       Impact factor: 1.088

6.  Impact of HbA1c measurement on hospital readmission rates: analysis of 70,000 clinical database patient records.

Authors:  Beata Strack; Jonathan P DeShazo; Chris Gennings; Juan L Olmo; Sebastian Ventura; Krzysztof J Cios; John N Clore
Journal:  Biomed Res Int       Date:  2014-04-03       Impact factor: 3.411

7.  Long-term prognostic value of admission haemoglobin A1c (HbA1c) levels in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Hamdi Pusuroglu; Ozgur Akgul; Huseyin Altug Cakmak; Mehmet Erturk; Ozgur Surgit; Omer Celik; Derya Ozturk; Fatih Uzun; Emre Akkaya; Aydın Yildirim
Journal:  Postepy Kardiol Interwencyjnej       Date:  2014-09-11       Impact factor: 1.426

8.  Relationship between glycated hemoglobin, Intensive Care Unit admission blood sugar and glucose control with ICU mortality in critically ill patients.

Authors:  Ata Mahmoodpoor; Hadi Hamishehkar; Kamran Shadvar; Mohammadtaghi Beigmohammadi; Afshin Iranpour; Sarvin Sanaie
Journal:  Indian J Crit Care Med       Date:  2016-02

9.  An Elevated Glycemic Gap is Associated with Adverse Outcomes in Diabetic Patients with Acute Myocardial Infarction.

Authors:  Wen-I Liao; Chin-Sheng Lin; Chien-Hsing Lee; Ya-Chieh Wu; Wei-Chou Chang; Chin-Wang Hsu; Jen-Chun Wang; Shih-Hung Tsai
Journal:  Sci Rep       Date:  2016-06-13       Impact factor: 4.379

10.  Prognostic value of HbA1c for in-hospital and short-term mortality in patients with acute coronary syndrome: a systematic review and meta-analysis.

Authors:  Wenjun Pan; Haining Lu; Baotao Lian; Pengda Liao; Liheng Guo; Minzhou Zhang
Journal:  Cardiovasc Diabetol       Date:  2019-12-11       Impact factor: 9.951

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.